Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.69 |
| ▸ | CCR6 | P51684 | 2/20 | 0.69 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.69 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.69 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.69 |
| ▸ | MGLL | Q99685 | 10/20 | 0.60 |
| ▸ | FAAH | O00519 | 5/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21840131 | 0.84 | MGLL (0.63) | ALDH1A1LMNAHSP90AA1TDP1CCR6 | |
| SCHEMBL19996137 | 0.83 | ALDH1A1 (0.96) | ALDH1A1LMNAHSP90AA1TDP1CCR6 | |
| SCHEMBL31119242 | 0.82 | ALDH1A1 (1.00) | ALDH1A1LMNAHSP90AA1TDP1CCR6 | |
| SCHEMBL9093746 | 0.80 | LMNA (0.71) | ALDH1A1LMNAMEN1KMT2APKM | |
| SCHEMBL95324 | 0.78 | MGLL (1.00) | ALDH1A1LMNAHSP90AA1TDP1CCR6 | |
| SCHEMBL23701480 | 0.77 | HSP90AA1 (0.65) | ALDH1A1LMNAHSP90AA1TDP1CCR6 | |
| SCHEMBL23701478 | 0.76 | HSP90AA1 (0.62) | ALDH1A1LMNAHSP90AA1TDP1CCR6 | |
| SCHEMBL20907468 | 0.75 | LMNA (0.54) | ALDH1A1LMNAMEN1KMT2APKM | |
| SCHEMBL13519327 | 0.74 | LMNA (0.58) | ALDH1A1LMNAMEN1KMT2APKM | |
| SCHEMBL2175616 | 0.73 | LMNA (0.62) | ALDH1A1LMNAMEN1KMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3074007-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS | INST NAT SANTE RECH MED (FR) | 2019-07-03 | — | — | EP | claimed |
| US-20170020847-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2017-01-26 | — | — | US | claimed |
| US-12631355-B2 | Root cause analytics of HVAC faults | HONEYWELL INTERNATIONAL INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260127556-A1 | AUTOCORRECTIVE FAILURE PREDICTIONS AND ASSISTANCE FOR COMMERCIAL BUILDINGS | HONEYWELL INT INC (US) | 2026-05-07 | — | — | US | disclosed |
| CN-121584663-A | Light storage straight-flexible load self-evolution collaborative scheduling method, system and equipment | 国网山东省电力公司潍坊供电公司 | 2026-02-27 | — | — | CN | disclosed |
| US-20250306577-A1 | SYSTEMS AND METHODS FOR MODELLING ASSETS IN A FACILITY | HONEYWELL INTERNATIONAL INC. | 2025-10-02 | — | — | US | disclosed |
| US-12422806-B2 | Building automation systems with automatic metadata tagging and viewing | TYCO FIRE & SECURITY GMBH (CH) | 2025-09-23 | — | — | US | disclosed |
| US-12412003-B2 | Building data platform with digital twin based predictive recommendation visualization | TYCO FIRE & SECURITY GMBH (CH) | 2025-09-09 | — | — | US | disclosed |
| US-12386827-B2 | Building data platform with a distributed digital twin | TYCO FIRE & SECURITY GMBH (CH) | 2025-08-12 | — | — | US | disclosed |
| US-12270560-B2 | Systems and methods for digital twin-based equipment control | JOHNSON CONTROLS TECHNOLOGY COMPANY (US) | 2025-04-08 | — | — | US | disclosed |
| CN-115289652-B | Water-cooled central air conditioner control method and device and water-cooled central air conditioner | 上海美控智慧建筑有限公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-1345943-B1 | INHIBITORS OF PAPILLOMA VIRUS | BOEHRINGER INGELHEIM CA LTD (CA) | 2007-03-21 | — | — | EP | disclosed |
| US-20060235010-A1 | DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2006-10-19 | — | — | US | disclosed |
| US-7119099-B2 | Inhibitors of papilloma virus | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2006-10-10 | — | — | US | disclosed |
| US-20050009855-A1 | 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2005-01-13 | — | — | US | disclosed |
| US-6759409-B2 | PREVENT VIRUS REPRODUCTION | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2004-07-06 | — | — | US | disclosed |
| EP-1345943-A2 | INHIBITORS OF PAPILLOMA VIRUS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-09-24 | — | — | EP | disclosed |
| US-20030064985-A1 | Inhibitors of papilloma virus | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2003-04-03 | — | — | US | disclosed |
| WO-2002050082-A2 | INHIBITORS OF PAPILLOMA VIRUS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-06-27 | — | — | WO | disclosed |
| WO-1998053790-A2 | COMPOUNDS THAT INHIBIT THE BINDING OF VASCULAR ENDOTHELIAL GROWTH FACTOR TO ITS RECEPTORS | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064985-A1 | Inhibitors of papilloma virus | REV1, CDKN1A, PCNA | ALDH1A1 339/4885LMNA 2414/4885HSP90AA1 4209/4885 |
| US-20260127556-A1 | AUTOCORRECTIVE FAILURE PREDICTIONS AND ASSISTANCE FOR COMMERCIAL BUILDINGS | ATP5MF, AHSA1, ATP5MK | ALDH1A1 3035/4885LMNA 2090/4885HSP90AA1 1678/4885 |
| US-20060235010-A1 | DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives | CCNE2, PCNA, POLL | ALDH1A1 687/4885LMNA 2207/4885HSP90AA1 2197/4885 |
| US-20170020847-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS | XPO1, XPOT, XPO6 | ALDH1A1 2667/4885LMNA 115/4885HSP90AA1 2691/4885 |
| US-12631355-B2 | Root cause analytics of HVAC faults | VAV1, TMCO1, HVCN1 | ALDH1A1 3968/4885LMNA 3983/4885HSP90AA1 175/4885 |
| US-20050009855-A1 | 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication | CCNE2, CCNE1, PCNA | ALDH1A1 323/4885LMNA 2394/4885HSP90AA1 2216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.